Literature DB >> 8546095

Insulin-like growth factor-I and angiographically documented coronary artery disease.

P Spallarossa1, C Brunelli, F Minuto, D Caruso, M Battistini, S Caponnetto, R Cordera.   

Abstract

In conclusion, we have reported an association between low IGF-I concentrations and CAD in relatively young men. This observation raises the possibility that IGF-I deficiency could be part of the polymetabolic syndrome. Whether a subnormal IGF-I production is due to growth hormone secretory abnormalities or to other metabolic reasons (e.g., insulin resistance or fat distribution, or both) is still unknown.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8546095     DOI： 10.1016/s0002-9149(96)90600-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  23 in total

1.  Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development.

Authors:  Daniela Milani; John D Carmichael; Joan Welkowitz; Steven Ferris; Richard E Reitz; Ann Danoff; David L Kleinberg
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 3.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

4.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

5.  Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Authors:  Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren
Journal:  Pediatr Diabetes       Date:  2014-12-10       Impact factor: 4.866

6.  Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.

Authors:  A Colao; S Spiezia; C Di Somma; R Pivonello; P Marzullo; F Rota; T Musella; R S Auriemma; M C De Martino; G Lombardi
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

7.  The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Hsiang-Ling Wang; Tsung-Po Chen; Shun-Fa Yang; Shu-Chen Chu; Yih-Shou Hsieh
Journal:  J Clin Lab Anal       Date:  2013-02-19       Impact factor: 2.352

Review 8.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

Review 9.  Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors:  P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

10.  Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance.

Authors:  Srinivas Martha; Narayana Pantam; Surender Thungathurthi; Vummentala L N Rao; Krishna Devarakonda
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.